2006;25:5885C97
2006;25:5885C97. induce BRCA2 degradation. BRCA2 is a practicable target for cancers therapy because BRCA2-lacking cells are hypersensitive to chemotherapeutic DNA damaging realtors. We present a marked aftereffect of O6BG pretreatment on cell awareness to cisplatin. We also demonstrate the efficiency of this strategy on an array of individual tumor cell lines, which implies that chemo-sensitization…